A bioequivalence study of amlitelimab delivered by 2 different devices in healthy adult participants

Trial Identifier:	BEQ19340
Sponsor:	Sanofi
Start Date:	August 2025
Primary Completion Date:	March 2026
Study Completion Date:	April 2026
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
UNITED STATES, Florida	Miami, Florida, UNITED STATES, 33014

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.